Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ
Closed
Oct 23, 2026
Day's Range
302.3752 wk Range
175.89Overview - LGND - Ligand Pharmaceuticals Incorporated
Key Statistics
Valuation
Enterprise Value
5.97B
P/E (Trailing)
31.98
P/E (Forward)
25.40
PEG Ratio
0.03
Price / Sales (TTM)
20.82
Price / Book
6.24
EV / EBITDA
44.93
Profitability
Gross Margin
94.95%
Profit Margin
67.88%
Operating Margin
13.48%
Return on Assets
3.99%
Return on Equity
21.96%
Ownership
Shares Outstanding
19.92M
Float
19.48M
Short % of Shares Outstanding
16.11%
Held by Insiders
2.32%
Held by Institutions
116.10%
Price stats
Beta
1.00
50-Day Avg
292.51
200-Day Avg
244.87
Dividends
Payout Ratio
0.00%
Analyst Consensus
11 analysts
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LGND - Ligand Pharmaceuticals Incorporated
Peers - LGND - Ligand Pharmaceuticals Incorporated
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- LGNDNASDAQLigand Pharmaceuticals Incorporated5.88BMarket Cap+38.72%52-week change31.98P/E (Trailing)67.88%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - LGND - Ligand Pharmaceuticals Incorporated
About
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that focuses on developing and licensing technologies and assets that support the discovery and development of medicines. Ligand Pharmaceuticals Incorporated operates a royalty-driven business model, partnering with other biopharmaceutical companies to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
